Assenagon Asset Management S.A. Sangamo Therapeutics, Inc Transaction History

Assenagon Asset Management S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	BUY	$0.3 - $0.63 $38,943 - $81,780	129,811 Added 14.37%	1,033,322 $557,000
Q3 2023 Nov 06, 2023	SELL	$0.58 - $1.47 $20 - $52	-36 Reduced -0.0%	903,511 $542,000
Q1 2023 Apr 18, 2023	BUY	$1.66 - $3.67 $64,917 - $143,522	39,107 Added 4.52%	903,547 $1.59 Million
Q4 2022 Jan 12, 2023	SELL	$2.77 - $5.07 $23,666 - $43,318	-8,544 Reduced 0.98%	864,440 $2.71 Million
Q3 2022 Oct 27, 2022	SELL	$4.27 - $6.39 $166 - $249	-39 Reduced -0.0%	872,984 $4.28 Million
Q1 2022 Apr 25, 2022	BUY	$5.23 - $7.82 $4.5 Million - $6.73 Million	860,547 Added 6897.62%	873,023 $5.07 Million
Q4 2021 Feb 01, 2022	BUY	$7.29 - $10.97 $90,950 - $136,861	12,476 New	12,476 $94,000
Q4 2020 Feb 01, 2021	SELL	$9.23 - $18.18 $3.07 Million - $6.05 Million	-332,611 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$9.38 - $12.48 $3.12 Million - $4.15 Million	332,611 New	332,611 $3.14 Million

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.